GABARAPL1 deficiency resulted in delayed tumour growth (Figure 6a, b) and was associated with reduced vessel density (31% difference, p = 0.005 (Figure 6c), as assessed by 9F1 immunohistochemistry. This evidence concerns the gene GABARAPL1 and neoplasm.